Autologous mitochondrial transplant after acute stroke complications
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies whether giving your own mitochondria (cell energy parts) can improve recovery after certain emergencies in the brain, such as blocked brain blood vessels or dangerous vessel spasm after a brain bleed. You might be considered if you can safely receive standard procedures and also get a brain MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an acute stroke-type blockage where a clot-busting procedure called thrombectomy is an option
- You also have acute brain blood-vessel spasm after an aneurysmal subarachnoid hemorrhage where angioplasty is planned
- There is enough time to explain the study and get consent from you or your legal decision-maker
- You are able to have a brain MRI scan
- You do not have a known mitochondrial disease
- You are stable enough for the usual endovascular procedures to be safely completed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a patient's own stem cells can be safely injected into the brain to help recovery after a stroke. It is for people who had an ischemic stroke 6 months to 5 years ago and still have moderate to severe symptoms.
This trial tests a new way to treat strokes caused by blockages in medium-sized brain arteries within 24 hours of symptom onset. It uses brain imaging to select patients who might benefit from a procedure to remove the clot.
This trial tests if a procedure to remove a large blood clot from the brain (called a thrombectomy) can help people with severe strokes who have a large damaged area. It is for people who can be treated within 24 hours of their stroke starting.
This trial tests whether a single injection of neural stem cells into the brain can improve motor function in people who had a stroke at least 6 months ago. It is for adults aged 18 to 75 with moderate movement difficulties.
This Phase 3 trial studies whether removing a clot using a catheter (endovascular thrombectomy) works better for certain types of acute ischemic stroke. It focuses on people with a blocked neck artery plus a blockage in the brain, and who can’t get or didn’t respond to IV clot-busting medicine.
This trial tests a surgical rescue treatment for people who have had a major stroke from a large artery blockage, but the standard clot removal procedure (thrombectomy) did not fully open the artery. The goal is to see if combining surgery with the earlier procedure can improve outcomes.
Hear when a new Cerebral Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.